-
effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
December 01, 2015 - “value-based pricing,” which may vary by indication and potential cost-
savings. … Whether this
will add to overall costs or offset costs of nonadherence to medication regimens is not … The additional variables that affect adherence
(e.g., medication affordability, access, side effects … : The manufacturer intends to set “value-based” pricing, depending on the situation and
potential cost … Whether these added costs
would offset costs of medication regimen nonadherence and whether patients
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - through a charitable donation program and to public health groups and low-income patients
via reduced pricing … this partnership, Kaléo will make
Evzio available at a discount, close to Federal Supply Schedule pricing … this partnership,
Kaléo will make Evzio available at a discount, close to Federal Supply Schedule pricing … Cost-effectiveness of
distributing naloxone to heroin users for lay
overdose reversal. … Evzio pricing info. [internet]. Santa Monica
(CA): GoodRx, Inc. [accessed 2014 Sep 09].
[6 p].
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - or phentermine-topiramate, and pricing for each
drug might change in a competitive market. … The online U.S. pharmacy-drug pricing resource, GoodRx, lists pricing for 30-day
supplies ranging from … can afford the cost. … cost of undergoing bariatric surgery or other antiobesity
surgical interventions. … reduce the cost burden of treating obesity-related complications.
-
effectivehealthcare-admin.ahrq.gov/products/diabetes-foot-ulcer-amputation-economics/research
December 01, 2019 - The cost of care for these beneficiaries is substantial, at about $33,000 for total reimbursement of … The actual national cost burden of diabetes is thought to exceed $174 billion, including the social cost … of intangibles such as pain and suffering, care provided by nonpaid caregivers, medical costs associated … with undiagnosed diabetes, and diabetes-attributed costs. … With this background in mind, the goal of this Data Points brief is to evaluate the utilization and costs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
November 01, 2016 - No cost, coverage, coding, or payment information is available yet, but elagolix
is expected to cost … Food and Drug Administration (FDA).4
Cost implications: No cost information is available yet, but elagolix … is expected to cost more
than available peptide GnRH receptor agonists, some of which are available … overall health care costs if patients drive demand for this drug. … Leuprolide (Lupron) pricing info. [internet]. Santa
Monica (CA): GoodRx, Inc.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
November 01, 2016 - No cost, coverage, coding, or payment information is available yet,
but elagolix is expected to cost … Food and Drug Administration (FDA).4
Cost implications: No cost information is available yet, but elagolix … is expected to cost more
than available peptide GnRH receptor agonists, some of which are available … overall
health care costs if patients drive demand for this drug. … Leuprolide (Lupron) pricing info. [internet]. Santa
Monica (CA): GoodRx, Inc.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/clinical-care-rapid-review-appendix-c.xlsx
January 01, 2018 - Post-implementation All liability costs, median cost rate NR 498 claims Median: 4 (IQR 1.16 to 9.31) … Post-implementation Lawsuit claim costs, median cost rate NR 498 claims Median: 0 (IQR 0 to 3.65) NA … NA NA
CRP Kachalia, 2010 Arm 1 Pre-implementation Lawsuit claim costs, mean cost rate NR 633 claims … Kachalia, 2010 Arm 1 Pre-implementation Non-lawsuit claim costs, mean cost rate NR 633 claims Mean: … Legal costs, median cost rate NR 498 claims Median: 0.19 (IQR 0.01 to 0.89) NA NA NA
CRP Kachalia,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
January 01, 2008 - hemoglobin or hematocrit
within the desired range, and 3) most effective interval of testing at the lowest cost … What are the benefits and associated costs of using hematologic measures such
as percentage of hypochromic … What are the benefits and associated costs of using hematologic measures such
as percentage of hypochromic … interval in which to measure markers of iron metabolic
status to achieve optimal outcomes at the lowest cost … renal disease (ESRD) is a risk factor for increased mortality,
morbidity, hospitalization, and medical costs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - If not, costs would increase to an extent. … Saxenda pricing info. [internet]. Santa Monica
(CA): GoodRx, Inc. [accessed 2015 Jun 01]. … Belviq (lorcaserin) pricing info. [internet]. Santa
Monica (CA): GoodRx, Inc. … Contrave pricing information. [internet]. Santa
Monica (CA): GoodRx, Inc. … Xenical pricing info. [internet]. Santa Monica
(CA): GoodRx, Inc. [accessed 2014 Oct 07].
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
June 01, 2014 - EES issued a self-funded cost study stating that the
anticipated per-procedure costs of using the Sedasys … Variables affecting adherence (e.g., medication
affordability, access, side effects) caused some skepticism … Cost: The cost of using the Sedasys system has not been released by the manufacturer, but it
could … acknowledged that digital medicines do not address several other
adherence variables (e.g., medication affordability … cost impact with postdischarge clinics, experts suggested, which could offset the initial cost
of
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s29.pdf
October 01, 2007 - Financial costs Costs include costs of administering the study, costs of the drugs, and costs of offering … Costs would not necessarily cease at the close of the study—additional costs
could accrue with further … Patients and employer
groups might also incur additional costs. … Concerns about financial costs were prominent. … Make plan “financially whole”; cover the costs of the study.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-254-rural-telehealth-app-e.xlsx
January 01, 2021 - Are All Important and Relevant Costs for Each Alternative Identified? … Are All Costs Measured Appropriately in Physical Units? Are Costs Valued Appropriately? … Is an Incremental Analysis of Costs and Outcomes of Alternatives Performed? … Are All Future Costs and Outcomes Discounted Appropriately?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - The wholesale cost was reported as $2,055 per month for 30 tablets, or
about $25,000 annually, a cost … Experts thought that tofacitinib might have more favorable pricing than injectable biologic
therapies … , which could lower costs
for patients. … Tofacitinib might have more favorable pricing than injectable biologic therapies (which
is yet to be … the cost of the biologics.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Hospitals
reporting device costs to ECRI Institute’s PriceGuide database reported a cost range of … A health systems expert opined that the high drug cost could be potentially equal to
the cost of treating … However, the change in care setting may result in more of a cost shift than a significant cost
reduction … The majority of the overall
treatment costs for these patients will continue to include the costs of … Juxtapid pricing info. [internet]. Santa Monica
(CA): GoodRx, Inc.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
January 01, 2011 - levels):
• I want the best treatment:
Clinical Outcome
Adverse
Events
Out-of-Pocket
Costs … the best treatment:
Clinical Outcome
C1 = 0.5
Adverse
Events
C2 = 0.33
Out-of-Pocket
Costs … reveals the implicit decision weights
patients attach to therapeutic benefits, harms, processes and costs … dosing schedule and monitoring), Side effects (any adverse event related to
drug use), and additional costs … schedule and
monitoring)
Side effects (any adverse event
related to drug use),
Additional costs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
June 01, 2015 - pursuing labeling for treating BPD or MDD, and third-party
payers generally do not reimburse its cost … informal clinical
practice listings and patient self-reports, IV ketamine treatments for BPD and MDD cost … Multiple experts also
opined that direct cost to patients, unresolved dosing protocols, and safety … Transderm Scop pricing. [internet]. Santa
Monica (CA): GoodRx, Inc. … Methscopolamine (Pamine Forte, Pamine)
pricing. [internet]. Santa Monica (CA): Good
Rx, Inc.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy_hi_impact.pdf
January 01, 2012 - The company reported that
an insured patient’s cost for the test would be no more than $235 and that … Many experts
believe while there may initial increase in costs, the reduction in costs stemming from … utero
surgery would increase health disparities based on patient access to this intervention and affordability … Regarding per-patient costs for this intervention, five experts agreed initial costs
might be high. … Experts speculated that the test cost would
likely be high and add to costs because it would not replace
-
effectivehealthcare-admin.ahrq.gov/products/medicare-utilization-seniors/research
December 01, 2019 - Thus, Medicare beneficiaries may face significant costs for their health care. … Some older adults face additional economic hardship from high costs for services not covered by Medicare … Long-term care costs are the primary reason older adults "spend down" their assets and become Medicaid … by dual-eligibles have focused on residents of long-term care facilities who have been forced by the costs … While seldom explicitly discussed, at least two States concluded that the cost of the Part A premiums
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-efficacy-and-comparative-effectiveness-of-pharmacological-and-nonpharmacological-treatments-for-adults-with-schizophrenia-what-are-the-harms-from-pharmacological-and-nonpharmacological-treatments-for-adults-with-
November 01, 2017 - In terms of health care costs there are significant increases in the rates of emergency visits hospitalizations … and medication related costs for individuals with schizophrenia as compared to a demographically adjusted … In addition to direct health care costs indirect costs and reductions in patients quality of life can
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
August 24, 2012 - Has it impacted cost? What can we learn about a proven paradigm? … Also, cost-sharing
and limits on coverage are discussed for some settings, but not others. … Both these factors further erode
potential cost savings from bundled payments. … We also note the
distinction between aggregate spending and
costs and per-episode spending and costs … We note the
distinction between aggregate spending/costs
and per-episode spending/costs in the same